Personalized T-cell therapies for hematologic malignancies and solid tumors.
Joined October 2021
- Tweets57
- Following146
- Followers55
- Likes0
We’d like to thank our dedicated team for their passion, hard work and commitment to making BlueSphere an incredible place to work!
Today, we announced the presentation of data that demonstrates the potential of our first and lead product candidate, BSB-1001, at this year’s 37th @sitcancer annual meeting. Learn more here: bit.ly/3hxKmNR #SITC2022
2
Our Chief Development Officer, Robert Keefe, Ph.D., is presenting data in a poster at this year’s 37th @sitcancer annual meeting. Learn more here: bit.ly/3UkFjOL
#ICYMI our team participated in The Leukemia & Lymphoma Society #LightTheNight walk and raised over $5K to support @LLSusa We’d like to thank our team for their support and dedication.
1
2
Today, we’re pleased to announce that Keir Loiacono, Esq., has been appointed Chief Executive Officer of BlueSphere Bio. Learn more here: bit.ly/3CxMmNW
#ICYMI we presented preclinical data supporting the ability of our TCXpress™ and iTCXpress™ platforms to rapidly and efficiently identify novel TCR candidates at the 7th annual CAR-TCR Summit. Check out our team in action below and learn more here: bit.ly/3Sp62tb
Today, we announced the presentation of preclinical data supporting the ability of our TCXpress™ and iTCXpress™ platforms to rapidly and efficiently identify novel TCR candidates, at the 7th annual CAR-TCR Summit. Learn more about the data here: bit.ly/3LRNnnd
1
At this year’s 7th Annual CAR-TCR Summit being held in Boston, MA from September 19 – 22, we’re presenting a poster highlighting our TCXpress™ and iTCXpress™ platforms. For more information, click here: bit.ly/3LrDPPE
1
At BlueSphere Bio, we’re expanding our team of talented individuals who share our passion for creating novel #CellTherapies for treating #cancer. Check out our current openings here: bit.ly/3prj3Xd #JobOpenings #Hiring
Our proprietary, high-throughput & efficient TCR capture, expression, and functional screening platform, TCXpress™ is capable of processing 1000s of single T cells directly into functionally expressed TCRs within a matter of days. Learn more here: bit.ly/3x4N1Uj
